Policy & Regulation

EU guides on the use of AI in medicines regulation

Read more

GLP-1 agonist shortages set to continue

Read more

Efpia: A competitive strategy for the future

Read more

More advanced planning needed for antimicrobials

Read more

New antibiotics pass regulatory hurdles

Read more

EU prepares for expansion of biotech

Read more

FDA guidance on drugs for early Alzheimer's disease

Read more

EMA reflects on 2023

Read more

A regulatory win for a rare disease strategy

Read more

EMA adopts AI workplan

Read more